Safety, Tolerability and Preliminary Efficacy of Erythrocyte-αPD-1 Conjugate in Patients With Advanced Malignancies
Clinical trial NCT06528249 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06528249
- Sponsor
- Zhejiang Provincial People's Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-31
- Primary completion
- 2026-07-31
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.